TY - JOUR T1 - A Note on COVID-19 Diagnosis Number Prediction Model in China JF - medRxiv DO - 10.1101/2020.02.19.20025262 SP - 2020.02.19.20025262 AU - Yi Li AU - Xianhong Yin AU - Meng Liang AU - Xiaoyu Liu AU - Meng Hao AU - Yi Wang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/17/2020.02.19.20025262.abstract N2 - Importance To predict the diagnosed COVID-19 patients and the trend of the epidemic in China. It may give the public some scientific information to ease the fear of the epidemic.Objective In December 2019, pneumonia infected with the novel coronavirus burst in Wuhan, China. We aimed to use a mathematical model to predict number of diagnosed patients in future to ease anxiety on the emergent situation.Design According to all diagnosis number from WHO website and combining with the transmission mode of infectious diseases, the mathematical model was fitted to predict future trend of outbreak.Setting Our model was based on the epidemic situation in China, which could provide referential significance for disease prediction in other countries, and provide clues for prevention and intervention of relevant health authorities.Participants In this retrospective, all diagnosis number from Jan 21 to Feb 10, 2020 reported from China was included and downloaded from WHO website.Main Outcome(s) and Measure(s) We develop a simple but accurate formula to predict the next day diagnosis number:,where Ni is the total diagnosed patient till the ith day, and α was estimated as 0.904 at Feb 10.Results Based on this model, it is predicted that the rate of disease infection will decrease exponentially. The total number of infected people is limited; thus, the disease will have limited impact. However, new diagnosis will last to March.Conclusions and Relevance Through the establishment of our model, we can better predict the trend of the epidemic in China.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIn this retrospective, all diagnosis number from Jan 21 to Feb 10, 2020 reported from China was included and downloaded from WHO website. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports ER -